Innovative agents highlight growth of targeted protein degradation platform and BMS' leadership in innovative cancer therapies
BioNTech and Bristol Myers Squibb will jointly execute a broad clinical development program to evaluate and advance BNT327 across numerous solid tumor types
Dasatinib Tablets is indicated for the treatment of (i) newly diagnosed adults with Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia
The safety profile of Opdualag observed in this analysis was consistent with the known profiles of nivolumab and relatlimab
Real-world and long-term extension data, including updated results from post-launch evaluation of REMS Program, bolster growing body of evidence supporting the efficacy and safety profile of CAMZYOS
He will lead the final stages of work to commission the 54,000-square-foot facility and then lead ongoing operations at the site
New analyses, including presentations on mavacamten, apixaban and milvexian, further solidify the company's strength and expertise as a leader in cardiovascular diseases
Second FDA approval for KRAZATI - reinforcing its potential across tumor types
KarXT, Karuna’s lead asset, is a potential first-in-class treatment for Schizophrenia
Seeks partnership between government and private medical colleges for providing superior medical education
Subscribe To Our Newsletter & Stay Updated
